🟢 Telix Pharmaceuticals is trading 6.54% up in after-hours trading as Pixclara’s PDUFA outcome remains unconfirmed

Telix Pharmaceuticals is trading 6.54% up at $12.03 in after-hours trading, supported by broader U.S. indexes gaining more than 0.5%.

• It closed at $11.29 on September 11, 2026, after declining 5.13% during the regular session.
• No confirmed September 11 company announcement or FDA decision was identified.
• Pixclara’s September 11 PDUFA date remains the key near-term catalyst; the FDA decision outcome is unconfirmed.